Andrea Lage

478 total citations
16 papers, 260 citations indexed

About

Andrea Lage is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Nephrology. According to data from OpenAlex, Andrea Lage has authored 16 papers receiving a total of 260 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Cardiology and Cardiovascular Medicine and 2 papers in Nephrology. Recurrent topics in Andrea Lage's work include Hormonal Regulation and Hypertension (9 papers), Heart Failure Treatment and Management (4 papers) and Diabetes Treatment and Management (4 papers). Andrea Lage is often cited by papers focused on Hormonal Regulation and Hypertension (9 papers), Heart Failure Treatment and Management (4 papers) and Diabetes Treatment and Management (4 papers). Andrea Lage collaborates with scholars based in United States, Germany and United Kingdom. Andrea Lage's co-authors include Luís M. Ruilope, Bertram Pitt, Stefan D. Anker, Peter Rossing, Marise Lazaretti‐Castro, George L. Bakris, Amer Joseph, José Gilberto H. Vieira, Gerasimos Filippatos and Rajiv Agarwal and has published in prestigious journals such as Circulation, Kidney International and Osteoporosis International.

In The Last Decade

Andrea Lage

13 papers receiving 254 citations

Peers

Andrea Lage

EDM

CCM

PRM

SURGE

Liang‐Liang Ding China

Shrita M. Patel United States

Dalong Zhu China

Pietro Vuotto Italy

Alokananda Ghosh United States

Yongkang Su China

Diana Moldovan Romania

Dírcea Rodrigues Portugal

Katja Blouin Germany

Aimee D Shu United States

Liang‐Liang Ding China

Andrea Lage

234 ×1.8

EDM

41 ×0.6

CCM

111 ×1.7

67 ×1.2

PRM

97 ×1.7

SURGE

Citations per year, relative to Andrea Lage Andrea Lage (= 1×) peers Liang‐Liang Ding

Countries citing papers authored by Andrea Lage

Since Specialization

Citations

This map shows the geographic impact of Andrea Lage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Lage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Lage more than expected).

Fields of papers citing papers by Andrea Lage

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Lage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Lage. The network helps show where Andrea Lage may publish in the future.

Co-authorship network of co-authors of Andrea Lage

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Lage. A scholar is included among the top collaborators of Andrea Lage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Lage. Andrea Lage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Kulac, Ian J., et al.. (2026). Finerenone, polypharmacy, and clinical outcomes in heart failure: pre-specified analysis from the FINEARTS-HF trial. European Journal of Heart Failure.

Navaneethan, Sankar D., Stefan D. Anker, Gerasimos Filippatos, et al.. (2025). Efficacy and safety of finerenone in patients with an acute change in estimated glomerular filtration rate in the prespecified FIDELITY pool analysis. Kidney International. 108(1). 136–144. 7 indexed citations

Butt, Jawad H., Pardeep S. Jhund, Alasdair Henderson, et al.. (2025). Finerenone, Glycaemic Status, and Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF Trial. European Journal of Heart Failure. 27(7). 1326–1341.

Chimura, Misato, Pardeep S. Jhund, Alasdair Henderson, et al.. (2025). Efficacy and Tolerability of Finerenone According to the Use and Dosage of Diuretics. JAMA Cardiology. 10(10). 979–979.

Desai, Akshay S., Pardeep S. Jhund, Muthiah Vaduganathan, et al.. (2025). Mode of Death in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction. JAMA Cardiology. 10(7). 678–678. 1 indexed citations

Vaduganathan, Muthiah, Brian Claggett, Ian J. Kulac, et al.. (2024). Effects of the Nonsteroidal MRA Finerenone With and Without Concomitant SGLT2 Inhibitor Use in Heart Failure. Circulation. 151(2). 149–158. 25 indexed citations

Bansal, Shweta, Maria Eugênia Fernandes Canziani, Rita Birne, et al.. (2024). Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trials. BMJ Open. 14(3). e076444–e076444. 10 indexed citations

Filippatos, Gerasimos, Stefan D. Anker, Phyllis August, et al.. (2023). Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis. European Heart Journal - Cardiovascular Pharmacotherapy. 9(2). 183–191. 24 indexed citations

Rossing, Peter, Stefan D. Anker, Gerasimos Filippatos, et al.. (2023). The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study. Diabetes Obesity and Metabolism. 25(10). 2989–2998. 8 indexed citations

10.

McGill, Janet B., Rajiv Agarwal, Stefan D. Anker, et al.. (2023). Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline. Diabetes Obesity and Metabolism. 25(6). 1512–1522. 9 indexed citations

11.

Ruilope, Luís M., Bertram Pitt, Stefan D. Anker, et al.. (2022). Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study. Nephrology Dialysis Transplantation. 38(2). 372–383. 39 indexed citations

12.

Rossing, Peter, Rajiv Agarwal, Stefan D. Anker, et al.. (2021). Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP‐1RA treatment: A subgroup analysis from the FIDELIO‐DKD trial. Diabetes Obesity and Metabolism. 24(1). 125–134. 47 indexed citations

13.

Camargo, Marília Brasilio Rodrigues, Maysa Seabra Cendoroglo, Luiz Roberto Ramos, et al.. (2005). Bone mineral density and osteoporosis among a predominantly Caucasian elderly population in the city of São Paulo, Brazil. Osteoporosis International. 16(11). 1451–1460. 41 indexed citations

14.

Lage, Andrea, Bernardo Liberman, Berenice B. Mendonça, et al.. (2005). High Degree of Discordance Between Three-Dimensional and Two-Dimensional Lumbar Spine Bone Mineral Density in Turner's Syndrome. Journal of Clinical Densitometry. 8(4). 461–466. 15 indexed citations

15.

Ohe, Monique Nakayama, Rodrigo Oliveira Santos, Andrea Lage, et al.. (2005). Changes in clinical and laboratory findings at the time of diagnosis of primary hyperparathyroidism in a University Hospital in São Paulo from 1985 to 2002. Brazilian Journal of Medical and Biological Research. 38(9). 1383–1387. 28 indexed citations

16.

Gomes, Samirah Abreu, Andrea Lage, Marise Lazaretti‐Castro, José Gilberto H. Vieira, & Ita Pfeferman Heilberg. (2004). Response to an oral calcium load in nephrolithiasis patients with fluctuating parathyroid hormone and ionized calcium levels. Brazilian Journal of Medical and Biological Research. 37(9). 1379–1388. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact